Correlation of Patient Generated-subjective Global Assessment with Serum C-reactive Protein Level in Stage I–IV Head-and-neck Cancer
DOI:
https://doi.org/10.3889/oamjms.2022.8488Keywords:
C-reactive protein, Head-and-neck cancer, Malnutrition, Patient generated-subjective global assessmentAbstract
AIM: This study aims to identify the correlation between patient generated-subjective global assessment (PG-SGA) with serum C-reactive protein (CRP) to be used to predict inflammation and prevent cachexia in head-and-neck cancer patients.
METHODS: This was a cross-sectional study using 51 patients with inclusion criteria of patients diagnosed with head-and-neck cancer irrespective of stage, age ≥18 years old, had not received treatments of radiotherapy, chemotherapy, and surgery. The statistical analysis performed was Kolmogorov–Smirnov normality test, bivariate analysis by Spearman test, and linear regression analysis.
RESULTS: As many as 64.7% of the patients had PG-SGA score ≥9 (average PG-SGA score 11.7 ± 6.2). The CRP median value was 6.4 (0.4–170.4) mg/L. There was a statistically significant positive but weak correlation between PG-SGA score with serum CRP (r = 0.372 and p = 0.007) and a significant linear relationship (r2 = 0.201).
CONCLUSIONS: Malnutrition risk assessment using PG-SGA showed a high prevalence of malnutrition risk in head-and-neck cancer patients. PG-SGA score is correlated with serum CRP level. Further studies are needed to confirm the result of this study.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8(8):1211. https://doi.org/10.3390/jcm8081211 PMid:31416154 DOI: https://doi.org/10.3390/jcm8081211
Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, et al. Diagnostic criteria for malnutrition-an ESPEN consensus statement. Clin Nutr. 2015;34(3):335-40. https://doi.org/10.1016/j.clnu.2015.03.001 PMid:25799486 DOI: https://doi.org/10.1016/j.clnu.2015.03.001
Kang MC, Kim JH, Ryu SW, Moon JY, Park JH, Park JK, et al. Prevalence of malnutrition in hospitalized patients: A multicenter cross-sectional study. J Korean Med Sci. 2018;33(2):e10. https://doi.org/10.3346/jkms.2018.33.e10 PMid:29215819 DOI: https://doi.org/10.3346/jkms.2018.33.e10
Marshall KM, Loeliger J, Nolte L, Kelaart A, Kiss NK. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin Nutr. 2019;38(2):644-51. https://doi.org/10.1016/j.clnu.2018.04.007 PMid:29789167 DOI: https://doi.org/10.1016/j.clnu.2018.04.007
Li Z, Chen W, Li H, Chinese Oncology Nutrition Survey Group. Nutrition support in hospitalized cancer patients with malnutrition in China. Asia Pac J Clin Nutr. 2018;27(6):1216-24. https://doi.org/10.6133/apjcn.201811_27(6).0007 PMid:30485919
de Pinho NB, Martucci RB, Rodrigues VD, D’Almeida CA, Thuler LC, Saunders C, et al. High prevalence of malnutrition and nutrition impact symptoms in older patients with cancer: Results of a Brazilian multicenter study. Cancer. 2020;126(1):156-64. https://doi.org/10.1002/cncr.32437 PMid:31497875 DOI: https://doi.org/10.1002/cncr.32437
Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, et al. Orphan disease status of cancer cachexia in the USA and in the European Union: A systematic review. J Cachexia Sarcopenia Muscle. 2019;10(1):22-34. https://doi.org/10.1002/jcsm.12402 PMid:30920776 DOI: https://doi.org/10.1002/jcsm.12402
Alshadwi A, Nadershah M, Carlson ER, Young LS, Burke PA, Daley BJ. Nutritional considerations for head and neck cancer patients: A review of the literature. J Oral Maxillofac Surg. 2013;71(11):1853-60. https://doi.org/10.1016/j.joms.2013.04.028 PMid:23845698 DOI: https://doi.org/10.1016/j.joms.2013.04.028
Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38(2):196-204. https://doi.org/10.1177/0148607113502674 PMid:24748626 DOI: https://doi.org/10.1177/0148607113502674
Haghjoo S. Malnutrition associated with head and neck cancers. Rev Clin Med. 2015;2:76-9.
Barker LA, Gout BS, Crowe TC. Hospital malnutrition: Prevalence, identification and impact on patients and the healthcare system. Int J Environ Res Public Health. 2011;8(2):514-27. https://doi.org/10.3390/ijerph8020514 PMid:21556200 DOI: https://doi.org/10.3390/ijerph8020514
Triarico S, Rinninella E, Cintoni M, Capozza MA, Mastrangelo S, Mele MC, et al. Impact of malnutrition on survival and infections among pediatric patients with cancer: A retrospective study. Eur Rev Med Pharmacol Sci. 2019;23(3):1165-75. https://doi.org/10.26355/eurrev_201901_17009 PMid:30779086
Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: Examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle. 2013;4(2):89-94. https://doi.org/10.1007/s13539-013-0111-0 PMid:23749718 DOI: https://doi.org/10.1007/s13539-013-0111-0
Gorenc M, Kozjek NR, Strojan P. Malnutrition and cachexia in patients with head and neck cancer treated with (chemo) radiotherapy. Rep Pract Oncol Radiother. 2015;20(4):249-58. https://doi.org/10.1016/j.rpor.2015.03.001 PMid:26109912 DOI: https://doi.org/10.1016/j.rpor.2015.03.001
Shaw C, Fleuret C, Pickard JM, Mohammed K, Black G, Wedlake L. Comparison of a novel, simple nutrition screening tool for adult oncology inpatients and the malnutrition screening tool (MST) against the patient-generated subjective global assessment (PG-SGA). Support Care Cancer. 2015;23(1):47-54. https://doi.org/10.1007/s00520-014-2319-8 PMid:24947056 DOI: https://doi.org/10.1007/s00520-014-2319-8
Naumann P, Eberlein J, Farnia B, Liermann J, Hackert T, Debus J, et al. Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation. Cancers (Basel). 2019;11(11):1655. https://doi.org/10.3390/cancers11111655 PMid:31717736 DOI: https://doi.org/10.3390/cancers11111655
Nagata M, Ito H, Matsuzaki T, Furumoto H, Isaka T, Nishii T, et al. Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer. Eur J Cardiothorac Surg. 2017;51(6):1164-70. https://doi.org/10.1093/ejcts/ezx004 PMid:28199511 DOI: https://doi.org/10.1093/ejcts/ezx004
Amano K, Maeda I, Morita T, Miura T, Inoue S, Ikenaga M, et al. Clinical implications of C-reactive protein as a prognostic marker in advanced cancer patients in palliative care settings. J Pain Symptom Manage. 2016;51:860-7. https://doi.org/10.1016/j.jpainsymman.2015.11.025 PMid:26826676 DOI: https://doi.org/10.1016/j.jpainsymman.2015.11.025
Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55(1):78-85. https://doi.org/10.1207/s15327914nc5501_10 PMid:16965244 DOI: https://doi.org/10.1207/s15327914nc5501_10
Orell-Kotikangas H, Österlund P, Saarilahti K, Ravasco P, Schwab U, Mäkitie AA. NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients. Support Care Cancer. 2015;23(6):1495-502. https://doi.org/10.1007/s00520-014-2500-0 PMid:25370893 DOI: https://doi.org/10.1007/s00520-014-2500-0
Donohoe CL, Ryan AM, Reynolds JV. Cancer cachexia: Mechanisms and clinical implications. Gastroenterol Res Pract. 2011;2011:601434. PMid:21760776 DOI: https://doi.org/10.1155/2011/601434
Wang CS, Sun CF. C-reactive protein and malignancy: Clinico-pathological association and therapeutic implication. Chang Gung Med J. 2009;32(5):471-82. PMid:19840504
Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, Liao CT, et al. Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma. PLoS One. 2013;8:e55327. https://doi.org/10.1371/journal.pone.0055327 PMid:23383155 DOI: https://doi.org/10.1371/journal.pone.0055327
Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155-70. https://doi.org/10.3109/10408363.2011.599831 PMid:22035340 DOI: https://doi.org/10.3109/10408363.2011.599831
Ingle PV, Patel DM. C-reactive protein in various disease condition-an overview. Asian J Pharm Clin Res. 2011;4:9-13.
Takenaka Y, Yamamoto M, Nakahara S, Yamamoto Y, Yasui T, Hanamoto A, et al. Factors associated with malnutrition in patients with head and neck cancer. Acta Otolaryngol. 2014;134(10):1079-85. https://doi.org/10.3109/00016489.2014.906750 PMid:25131392 DOI: https://doi.org/10.3109/00016489.2014.906750
Yoshida T, Delafontaine P. Mechanisms of cachexia in chronic disease states. Am J Med Sci. 2015;350(4):250-6. https://doi.org/10.1097/MAJ.0000000000000511 PMid:26083652 DOI: https://doi.org/10.1097/MAJ.0000000000000511
Lee S, Choe JW, Kim HK, Sung J. High-Sensitivity C-reactive protein and cancer. J Epidemiol. 2011;21(3):161-8. https://doi.org/10.2188/jea.je20100128 PMid:21368452 DOI: https://doi.org/10.2188/jea.JE20100128
de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp. 2012;27(3):707-14. https://doi.org/10.3305/nh/2012.27.3.5567 PMid:23114934
Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer. 2010;18:433-7. https://doi.org/10.1007/s00520-009-0681-8 PMid:19562384 DOI: https://doi.org/10.1007/s00520-009-0681-8
Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle. 2011;2(1):27-35. https://doi.org/10.1007/s13539-011-0022-x PMid:21475618 DOI: https://doi.org/10.1007/s13539-011-0022-x
Downloads
Published
How to Cite
License
Copyright (c) 2022 Anastasya Siregar, Dian Novita Chandra, Ikhwan Rinaldi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0